Ranitidine Hydrochloride

• CAT Number: A001075
• CAS Number: 66357-59-3
• Molecular Formula: C13H23ClN4O3S
• Molecular Weight: 350.90
• Purity: ≥95%
• Synonyms: AH19065; ZANTAC; Ranitidine HCL; 66357-59-3; Fendibina; Gastridina
• Target: Neuronal Signaling
• Solubility: Soluble in DMSO > 10 mM
• Storage: -20°C
• IUPAC Name: (E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine;hydrochloride
• InChI: InChI=1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H/b13-9+
• InChIKey: GGWBHVILAJZWKJ-KJEVSKRMSA-N
• SMILES: CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl

Ranitidine Hydrochloride（Cat No.:A001075）is a histamine H2-receptor antagonist used to treat and prevent gastrointestinal conditions such as ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. It works by reducing stomach acid production, thereby alleviating symptoms like heartburn and promoting healing of the stomach lining. Ranitidine provides effective relief from acid-related discomfort and is used both for short-term and maintenance therapy. Its efficacy and safety profile made it a popular choice for acid suppression before concerns over impurities led to its market withdrawal in many regions.